{"nct_id":"NCT01580228","title":"A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2012-08","start_date_type":null,"primary_completion_date":"2014-12","primary_completion_date_type":"ACTUAL","completion_date":"2014-12","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}